The medical technology company Bibb Instruments has received additional subscription intentions in its ongoing rights issue of approximately SEK 60 million, according to a press release.It is the company's largest issue guarantor, Life Science Invest Fund (LSIF), which has announced that it intends to subscribe for shares without subscription rights for an additional SEK 2 million, which increases their total intended subscription amount to SEK 4 million. “By increasing our investment, LSIF strengthens its support for the ongoing USA launch and the planned European launch, as we believe that the current valuation constitutes an attractive entry point for institutional capital with a focus on long-term value creation,” comments Jan Poulsen, CEO of LSIF.In addition, the CEO and the chair of the board have increased their subscription commitments to approximately SEK 300,000 each.